Combinatorial Effects of Plasma-Treated Solution and Plasma-Treated Hydrogel with Cisplatin in Vulvar Cancer Cells
Oncology Research · 2026
DOI: 10.32604/or.2026.081755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Estelle C I D Schad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's Health Tübingen, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Cisplatin, Plasma Gases, Vulvar Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Vulvar squamous cell carcinoma (VSCC) is a rare, but increasingly prevalent malignancy with limited therapeutic options in the advanced disease state. Cisplatin-based chemoradiation remains the standard of care but is constrained by cumulative toxicity. Precancerous lesions, including high-grade squamous intraepithelial lesions (HSIL) and differentiated vulvar intraepithelial neoplasia (dVIN), similarly require effective yet tolerable treatments. Low-thermal Argon plasma devitalization (ltAPD), a source of reactive oxygen and nitrogen species (RONS), has emerged as a promising approach for redox-based tumor modulation. This study aimed to evaluate the anti-tumor efficacy of two plasma modalities, plasma-treated solution (PTS) and plasma-treated hydrogel (PTH) in combination with cisplatin in VSCC cells.
Methods
PTS and PTH were applied as monotherapies and in sequential combination with cisplatin (plasma-first vs. cisplatin-first). RONS kinetics, cell viability, and treatment interactions were assessed following plasma monotherapy and sequential combination with cisplatin. Apoptosis and redox balance were evaluated by caspase-3/7 activity and GSH/GSSG ratios, respectively.
Results
PTS induced a rapid oxidative burst, whereas PTH enabled delayed and sustained RONS release. Both modalities reduced cell viability in a time-dependent manner, with rapid cytotoxic effects observed for PTS. Plasma pre-treatment enhanced cisplatin efficacy, with higher synergy scores in the plasma-first sequence. Increased caspase-3/7 activity and decreased GSH/GSSG ratios, observed in the combination treatment of plasma and cisplatin, indicated enhanced oxidative stress and apoptotic priming.
Conclusions
PTS and PTH exhibit intrinsic anti-tumor activity and sensitize VSCC cells to cisplatin through redox modulation. These findings support the integration of plasma-based strategies into combinatorial therapeutic approaches for VSCC and its precancerous lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
- Natural and Medical Sciences Institute (NMI), University of Tübingen, Reutlingen, Germany.
Zitieren
APA
Schad, E. C. I. D., Xavier, J. P. R., Decool, H., Arnholdt, M., Keßler, F., Schöttke, J., Brucker, S. Y., Oberlechner, E., Laupp, J., & Weiss, M. (2026). Combinatorial Effects of Plasma-Treated Solution and Plasma-Treated Hydrogel with Cisplatin in Vulvar Cancer Cells. Oncology Research. https://doi.org/10.32604/or.2026.081755
Vancouver
Schad ECID, Xavier JPR, Decool H, Arnholdt M, Keßler F, Schöttke J, et al. Combinatorial Effects of Plasma-Treated Solution and Plasma-Treated Hydrogel with Cisplatin in Vulvar Cancer Cells. Oncology Research. 2026. doi:10.32604/or.2026.081755
BibTeX
@article{Schad2026,
author = {Schad, Estelle C I D and Xavier, Janet P Raja and Decool, Hortense and Arnholdt, Marcel and Keßler, Franziska and Schöttke, Jan and Brucker, Sara Y and Oberlechner, Ernst and Laupp, Johanna and Weiss, Martin},
title = {Combinatorial Effects of Plasma-Treated Solution and Plasma-Treated Hydrogel with Cisplatin in Vulvar Cancer Cells},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.081755}
}
EUVIMED